A 55-year-old woman developed painful, red facial and neck lesions with fever two days after starting inhaled indacaterol/glycopyrronium for COPD. Blood tests showed neutrophilia; biopsy confirmed Sweet syndrome.
Lesions improved with corticosteroids after stopping the drug. This is the first reported case linked to inhaled therapy, highlighting the need for primary care awareness of rare drug reactions and the importance of ruling out systemic disease.
Passengers are done being polite. What used to be a rare annoyance is now a full-blown in-flight epidemic: people blasting TikToks, movies, and video calls into the…
Prom was supposed to be my breaking point. That’s what she wanted. No dress, no help, just her smirk and the reminder that my mom was gone,…
The bill hit like a verdict. Laughter died, forks froze, and every eye turned to the number that said what no one dared: I was expected to…
He was burning while she was laughing. Flames ate through his skin as she sipped cocktails in another man’s arms, confident the upgraded policy would turn his…
The room turned on me like a pack of wolves. My sister’s voice dripped poison, my parents watched like executioners, and two hundred witnesses waited to see…
The silence after the wedding was louder than any song that played that night. In the dim light of their honeymoon suite, a single confession cracked through…